AI-generated summary
The authors retrospectively reviewed 79 patients with cesarean scars treated with fractional CO2 laser between 2016 and 2020. They report significant improvements on the Vancouver Scar Scale, the UNC 4P Scar Scale and several Antera3D measures, with no long-term complications during follow-up. The retrospective design without a control group limits how strongly the results can be interpreted.
- Participants
- 79
- Who or what was studied
- Patients with cesarean scars who received fractional CO2 laser therapy between January 2016 and January 2020
- Limits stated in the abstract
- The study is retrospective, and the abstract reports no control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Melanin. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.